The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design (Q36547207)

14 August 2017

1 reference

title

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design (English)

1 reference

14 August 2017

0 references

1 reference

1 reference

Thomas A Waldmann

1

1 reference

14 August 2017

publication date

1 August 2006

1 reference

Nature Reviews Immunology

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

595-601

1 reference

The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID

14 August 2017

cites work

1 reference

Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor

31 March 2020

1 reference

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

31 March 2020

1 reference

Interleukin 15: biology and relevance to human disease

31 March 2020

1 reference

The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells

31 March 2020

1 reference

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

31 March 2020

1 reference

Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor

31 March 2020

1 reference

The IL-2/IL-2 receptor system: a current overview

31 March 2020

1 reference

Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation

31 March 2020

1 reference

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

31 March 2020

1 reference

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

31 March 2020

1 reference

IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice

31 March 2020

1 reference

Interleukin-2 and interleukin-15: immunotherapy for cancer.

31 March 2020

1 reference

A potential role for interleukin-15 in the regulation of human natural killer cell survival

31 March 2020

1 reference

Fas and the art of lymphocyte maintenance

31 March 2020

1 reference

A function for interleukin 2 in Foxp3-expressing regulatory T cells

31 March 2020

1 reference

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

31 March 2020

1 reference

Fueling regulation: IL-2 keeps CD4+ Treg cells fit

31 March 2020

1 reference

Transregulation of memory CD8 T-cell proliferation by IL-15Rα+ bone marrow–derived cells

31 March 2020

1 reference

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells

31 March 2020

1 reference

Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia

31 March 2020

1 reference

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

31 March 2020

1 reference

Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4

31 March 2020

1 reference

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation

31 March 2020

1 reference

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

31 March 2020

1 reference

Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells

31 March 2020

1 reference

Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain

31 March 2020

1 reference

Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study

31 March 2020

1 reference

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

31 March 2020

1 reference

T cell-independent interleukin 15Ralpha signals are required for bystander proliferation

31 March 2020

1 reference

Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2

31 March 2020

1 reference

IL-15 Mediates Anti-tumor Effects after Cyclophosphamide Injection of Tumor-Bearing Mice and Enhances Adoptive Immunotherapy: The Potential Role of NK Cell Subpopulations

31 March 2020

1 reference

Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response.

31 March 2020

1 reference

Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance

31 March 2020

1 reference

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

31 March 2020

1 reference

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

31 March 2020

1 reference

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

31 March 2020

1 reference

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

31 March 2020

1 reference

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation

31 March 2020

1 reference

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

31 March 2020

1 reference

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial

31 March 2020

1 reference

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta

31 March 2020

1 reference

Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the

31 March 2020

1 reference

The meandering 45-year odyssey of a clinical immunologist

31 March 2020

1 reference

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

31 March 2020

1 reference

IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients

31 March 2020

1 reference

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

31 March 2020

1 reference

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

31 March 2020

1 reference

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

31 March 2020

1 reference

Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis

31 March 2020

1 reference

Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo

31 March 2020

1 reference

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease

31 March 2020

1 reference

Role of cytokines in rheumatoid arthritis

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI1901

1 reference

14 August 2017

1 reference